Dr. Prasad is the Head of Protein Sciences at Ventus Therapeutics. Prior to Ventus, Sridhar was the cofounder and CSO of Plex Pharmaceuticals and led structural biology efforts for drug discovery programs at multiple organizations in various capacities. He was a member of the Nesina® discovery team at Syrrx, a diabetes drug and MK-4965 at Merck, clinical candidate for treatment of AIDS. Sridhar was Principal Investigator on a number of NIH SBIR and MJFF funded grants. Sridhar obtained his PhD from Indian Institute of Science, Bangalore, India and Post-doctoral training from University of Minnesota Medical School and Scripps Research Institute, California